Berwind Private Equity Invests in ThermImage, Inc.

6/30/2010

Berwind Private Equity is pleased to announce our investment in ThermImage, Inc. a Salt Lake City based medical device development company. ThermImage has developed and patented an alternative to the current diagnosis of Vesicoureteral Reflux (VUR). ThermImage's device will provide a non-invasive, safe, reliable, comfortable and cost effective imaging test for detecting pediatric VUR. The new device will eliminate a majority of the VCUG and nuclear cystogram procedures used to detect VUR, increase the detection rate, reduce the usage of unnecessary antibiotics, and help prevent devestating health consequences later in life.